Understanding Chronic Treatments by Patients Over 65 Years of Age
NCT ID: NCT07241299
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2025-11-17
2026-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This multi-morbidity is associated with polypharmacy, which is a recognised risk factor for poor treatment compliance.
One of the causes of poor compliance is a lack of understanding of the treatment. In this context, the role of the general practitioner is central. General practitioners are responsible for more than three-quarters of medical prescriptions. They are the ones who initiate first-line treatments for chronic diseases, but also the ones who renew treatments introduced by specialists.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Collaborative Approach to Medication Reviews for Older Patients With Polypharmacy
NCT03909035
Serious Adverse Drug Reaction and Their Preventability
NCT02888834
Observatory on Elderly Patients "Les S.AGES"
NCT01065909
Impact of a Mobile Geriatric Team With a Pharmacist on the Optimisation of Prescriptions in Elderly Inpatients
NCT04151797
Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older
NCT02598115
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary: To investigate the factors associated with the understanding of chronic treatments by patients over 65 years of age.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
data collection
Data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consulting one of the general practitioners agreeing to participate in the study
* Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months)
* Agree to participate in the study.
Exclusion Criteria
* Has neurocognitive disorders
* Lives in a medical facility
* Consulting for an acute condition and whose prescription does not include chronic treatment.
* Protected by law (guardianship, curatorship, judicial protection),
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Reims Champagne-Ardenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gestonnairedu CURRS
Reims, Université de Reims Champagne-Ardenne, France
Ufr Medecine Urca
Reims, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025_RIPH_02_ordonnance
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.